As a leading pharmaceutical manufacturer, Pluvia Endo is committed to providing high-quality medications to improve patient outcomes. One of our prominent products is Faroxy, which contains oxycodone, a potent opioid analgesic. It affects managing moderate to severe pain.

This blog post aims to provide essential information regarding the dosage and administration of Faroxy. It includes the various formulations we offer. For instance, we produce Oxycodone Immediate-Release (IR) 5 mg, 15 mg, 30 mg. Furthermore, we produce Oxycodone Extended-Release (ER) 10 mg, 20 mg, and 40 mg.

Understanding Faroxy (Oxycodone)

Oxycodone is a powerful opioid analgesic that works by binding to specific receptors in the brain and spinal cord. It also alters the perception of pain. So, it is crucial to administer oxycodone carefully. Afterward, It considers the patient’s individual pain management needs, previous opioid exposure, and overall health status. Oxycodone can be highly addictive. So, healthcare providers must exercise caution when prescribing this medication.

Dosage Forms and Strengths of Faroxy

Pluvia Endo produces several formulations of Faroxy, allowing healthcare providers to tailor pain management strategies to individual patient needs:

Immediate-Release (IR)

Oxycodone Immediate-Release (IR) 5 mg

These tablets are effective in providing rapid pain relief. They are also typically effective in acute pain or breakthrough pain management. The 5 mg strength often affects a starting dose for opioid-naïve patients or those with lower pain thresholds.

Oxycodone Immediate-Release (IR) 15 mg

The 15 mg IR formulation is a higher-strength option. It is suitable for patients with more severe pain. The 15 mg IR formulation is also ideal for those who have developed tolerance to lower doses of oxycodone. It offers faster-acting pain relief compared to extended-release formulations.

Oxycodone Immediate-Release (IR) 30 mg

The 30 mg IR tablet affects patients with the most severe pain or those who have developed a tolerance to lower doses of oxycodone. It should be used cautiously and under close medical supervision due to the increased risk of adverse effects and potential for misuse.

Extended-Release (ER)

Oxycodone Extended-Release (ER) 10 mg

The 10 mg ER formulation effects to provide long-lasting pain relief for patients with chronic pain. It is also typically administered every 12 hours and is not intended for acute pain management or as a rescue medication.

Oxycodone Extended-Release (ER) 20 mg

The 20 mg ER tablet is a higher-strength option suitable for patients with more severe chronic pain or those who have developed tolerance to lower doses of oxycodone ER. It offers continuous pain relief for up to 12 hours.

Oxycodone Extended-Release (ER) 40 mg

Healthcare providers reserve the 40 mg ER formulation for patients with the most severe chronic pain or those who have developed a tolerance to lower doses of oxycodone ER. They should use it cautiously and under close medical supervision due to the increased risk of adverse effects and potential for misuse.

General Dosage Guidelines

The initial dose of Faroxy must be individualized based on the severity of pain, previous analgesic experience, and the patient’s overall health. For opioid-naïve patients, we recommend starting with the lowest effective dose, typically 5 mg for IR formulations or 10 mg for ER formulations.

1. Titration: Healthcare providers should make dosage adjustments based on the patient’s response to treatment. If pain relief is inadequate, they may increase the dose by 25% to 50%. It is essential to monitor the patient closely for signs of respiratory depression and other adverse effects, especially during the first 24 to 72 hours of treatment initiation or after any dosage increase.
2. Administration Schedule:

• Immediate-Release (IR): For IR formulations, the dosing interval is typically every 4 to 6 hours as needed for pain relief. Patients should take the medication with or without food, depending on their tolerance and preference.
• Extended-Release (ER): ER formulations are administered every 12 hours. Patients should swallow the tablets whole, without cutting, breaking, or chewing, to avoid rapid release and potential overdose. They can take ER tablets with or without food, but they need to maintain consistency in dosing.

4. Conversion from Other Opioids: When converting patients from other opioids to Faroxy, it is crucial to use appropriate equianalgesic dosing guidelines. For instance, 10 mg of oral oxycodone is approximately equivalent to 20 mg of oral morphine. Healthcare providers should carefully evaluate the patient’s previous opioid exposure. They also should adjust the starting dose of Faroxy accordingly to minimize the risk of adverse effects or withdrawal symptoms.
5. Special Populations:

• Elderly Patients: The starting dose for elderly patients should be conservative, typically reduced by 50% due to increased sensitivity to opioids and the higher prevalence of comorbidities and concomitant medications.
• Patients with Renal or Hepatic Impairment: Dosage adjustments may be necessary for patients with renal or hepatic dysfunction. We recommend using a conservative starting dose for elderly patients, typically reduced by 50% due to increased sensitivity to opioids and the higher prevalence of comorbidities and concomitant medications.

Safety and Monitoring of Faroxy

Patients receiving Faroxy should do it carefully for signs of sedation, respiratory depression, and potential misuse or addiction. It is essential to discuss with patients the risks associated with opioid therapy, including the importance of adhering to the prescribed dosage and the need for naloxone availability in case of overdose. Regular follow-up visits and assessments of pain management and functional status are crucial to ensure the safe and effective use of Faroxy.

Conclusion

At Pluvia Endo, we prioritize patient safety and effective pain management through our high-quality Faroxy formulations. Understanding the appropriate dosage and administration guidelines is vital for healthcare providers to ensure optimal outcomes for patients suffering from moderate to severe pain.

Always consult with a healthcare professional for personalized dosing recommendations and adjustments based on individual patient needs.

For more information on Faroxy and our other pharmaceutical products, please visit our website or contact our customer service team. Your health and well-being are our top priorities.